Establish a robust contamination control program with STERIS's SurePath Disinfectant Efficacy Testing™ (DET) Program. Ideal for pharmaceutical, biopharmaceutical (including cell and gene therapy) and medical device manufacturers, our streamlined, science-based in vitro studies help you select and validate the optimal cleaning and disinfection chemistries for your unique environment.
With extensive experience and resources, our team efficiently guides projects of any size, saving you time – allowing your organization to focus on value-added activities that support quality, consistency and regulatory compliance.
The SurePath DET Difference:
Your first step toward a validated contamination control program starts here.
Your needs are unique – so is our approach. Discover how a partnership with STERIS can reduce risk and improve sustainability and efficiency at your facility.
Contact Us